SNY vs TAK: stock comparison and AI forecast
Sanofi (SNY) and Takeda Pharmaceutical Co Ltd (TAK) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
SNY Sanofi
- Price
- $47.04 +8.9% · 6M
- Market Cap
- $115.97B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
TAK Takeda Pharmaceutical Co Ltd
- Price
- $21.19 +27.3% · 6M
- Market Cap
- $66.19B
- P/E Ratio
- 6.4x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- SNY is 1.8 times larger than TAK by market capitalization ($115.97B against $66.19B).
- Over the last six months TAK returned +27.3% and SNY +8.9%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | SNY | TAK |
|---|---|---|
| Market Cap | $115.97B | $66.19B |
| P/E Ratio | – | 6.38x |
| EPS | – | $3.32 |
| Revenue/Share | – | $34.55 |
| FCF/Share | – | $6.79 |
Profitability & Margins
| Metric | SNY | TAK |
|---|---|---|
| ROE | 30.0% | – |
| ROA | 16.9% | – |
| ROIC | 20.7% | – |
| Gross Margin | – | 67.4% |
| Operating Margin | – | 9.2% |
| Net Margin | – | 4.9% |
| EBT Margin | – | 5.5% |
| Tax Rate | – | 11.7% |
Financial Health
| Metric | SNY | TAK |
|---|---|---|
| Current Ratio | 1.09x | – |
| Quick Ratio | 0.73x | – |
| Financial Leverage | 1.78x | – |
| Working Capital | $3.06B | – |
Cash Flow
| Metric | SNY | TAK |
|---|---|---|
| Operating Cash Flow | $28.11B | $25.43B |
| Free Cash Flow | – | $21.23B |
| Capital Spending | – | -$4.20B |
| OCF Growth YoY | -11.9% | – |
| FCF Growth YoY | – | 0.0% |
| FCF/Sales | – | 19.7% |
| CapEx/Sales | – | 3.9% |
Operational Efficiency
| Metric | SNY | TAK |
|---|---|---|
| Inventory Turnover | 3.8x | – |
| Days Inventory | 96 days | – |
Income Statement
| Metric | SNY | TAK |
|---|---|---|
| Total Revenue | – | $107.93B |
| Operating Income | $23.11B | $9.90B |
| Net Income | $24.28B | $5.25B |
| R&D Expense | $25.35B | $17.20B |
| SG&A Expense | $32.28B | – |
| Cost of Goods Sold | $44.17B | $35.17B |
Dividend & Shareholder Information
| Metric | SNY | TAK |
|---|---|---|
| Shares Outstanding | 2465M | 3124M |
| Net Income Growth | 5.1% | – |
SNY vs TAK: stock comparison and AI forecast
Which is bigger, SNY or TAK?
SNY is 1.8 times larger than TAK by market capitalization ($115.97B against $66.19B).
Which stock performed better over the last six months, SNY or TAK?
Over the last six months TAK returned +27.3% and SNY +8.9%.
Which one does Intratio's AI model rank higher, SNY or TAK?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.